Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
Status:
Terminated
Trial end date:
2018-02-26
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomised, placebo-controlled, two-part adaptive clinical trial. The
trial is designed to investigate the efficacy and safety of multiple dosing regimens of
selepressin and to confirm the efficacy and safety of one dosing regimen in treatment of
adult patients with septic shock requiring vasopressor.